Related Experiment Video
Updated: Aug 6, 2026

10:19
Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Published on: November 10, 2014
Multinodular goitre: 'much more to it than simply iodine deficiency'
1Department of Medicine, St. Heduig Hospital and Humboldt University Berlin, Grosse Hamburger Str. 5-11, Berlin, 10115, Germany.
Summary
Multinodular goitre (MNG) is not solely caused by iodine deficiency. Research suggests MNGs are benign neoplasias driven by the intrinsic growth potential of thyroid cells, impacting clinical management.
Area of Science:
- Endocrinology
- Thyroidology
- Pathology
Background:
- Multinodular goitre (MNG) has historically been attributed to iodine deficiency.
- This traditional view is challenged by MNG's prevalence in iodine-sufficient regions and its complex characteristics.
- Features like multinodularity, functional heterogeneity, and autonomous growth do not align with simple iodine deficiency.
Purpose of the Study:
- To re-evaluate the pathogenesis of multinodular goitre.
- To investigate the underlying mechanisms driving MNG development and heterogeneity.
- To explore the implications of new pathogenetic concepts on MNG clinical management.
Main Methods:
- Review of existing literature and recent investigations on MNG.
- Analysis of MNG characteristics inconsistent with the iodine deficiency model.
- Conceptual framework development based on intrinsic cellular growth potential.
Main Results:
- MNGs are proposed to be benign neoplasias arising from genetically predetermined thyrocytes with high intrinsic growth potential.
- Functional and structural heterogeneity in MNG is attributed to metabolic and functional differences among individual thyrocytes.
- Iodine deficiency influences MNG epidemiology but not its fundamental pathogenetic mechanisms.
Conclusions:
- The concept of MNG as a simple consequence of iodine deficiency is outdated.
- MNG pathogenesis involves the inherent growth potential and heterogeneity of thyroid follicular cells.
- New pathogenetic insights necessitate a re-evaluation of clinical management strategies for MNG.
Related Concept Videos
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

